Abstract
Impact of Novel Therapies (NTs) on Real-World (RW) Clinical Outcomes of Patients (pts) with Relapsed/Refractory (RR) Mantle-Cell Lymphoma (MCL) By Race/Ethnicity and TP53 Mutation Status
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have